FDA recall, , Moderate risk
Helena Laboratories V8 Serum Protein SPE Kit
The V8 Serum Protein SPE Kit's diluent shows a reproducible shift in quality control results relative to historical or comparator diluent.
What happened
Helena Laboratories, Corp., of Beaumont, Texas, is recalling its V8 Serum Protein SPE Kit. The company started the recall on its own, beginning September 14, 2026. Assayed quality control material run with kits manufactured using a diluent lot shows a reproducible shift in serum protein electrophoretic fraction distribution.
Compared with historical or comparator diluent lots, decreased albumin is approximately 6 to 10 relative percentage points. Increased beta and gamma globulin fractions are approximately 1 to 3 relative percentage points.
The affected diluent is V8 SPE Diluent, a component of the finished kit. Distribution was worldwide, with US nationwide distribution in California, Florida, Indiana, Michigan, Mississippi, Missouri, Tennessee and Texas. The Food and Drug Administration added the recall to its Enforcement Report on November 17, 2026.

What to do
If a code on your device is listed below:
- Check the lot against the recall notice and ask your provider or supplier before you stop using it.
Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.
Is your kit affected?
Compare every listed detail under your product with its label.
V8 Serum Protein SPE Kit, Cat. No.: 1805, containing V8 SPE Diluent
- Model number
- 552512
- Product code
- 552512
- Other code
- M52518050
- Lot code
- 4-26-1805
- 3-26-552512
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 16, 2026
- Sold in
Distributed in Michigan, California, Tennessee, Mississippi, Missouri, Texas, Indiana and Florida, and in Paraguay, Canada, Israel, the Philippines and Trinidad and Tobago.
- Recalled by
- Helena Laboratories, Corp.Beaumont, Texas
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 99987
- Recall number
- Z-0469-2027
- Recall type
- Started by the company
All recalls from Helena Laboratories, Corp.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Helena Laboratories began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary

